StockData
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

INTELLIGENT BIO SOLUTIONS INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026
$1.53+0.03 (+2.00%)

Close on Oct 19, 2026

Market cap
$3.83M
P/E (TTM)
–
Dividend yield
–

INTELLIGENT BIO SOLUTIONS INC. revenue by segment

By business segment

By product or service

RevenueQ4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24% of revenueYoY
Sales of Goods - Cartidges [Member]$624.97K$703.54K$516.75K$640.30K$483.31K$442.03K$388.30K$448.51K$389.53K$448.87K$330.95K$380.06K54.5%+29.3%
Other sales - accessories [Member]$291.41K$217.86K$133.50K–$169.21K$121.04K$98.41K–––––25.4%+72.2%
Sales of Goods - Readers [Member]$229.42K$139.41K$246.52K$286.91K$191.36K$165.80K$120.79K$233.79K$186.85K$227.36K$285.89K$238.80K20.0%+19.9%
Other Sales [Member]–––$184.58K$169.21K$121.04K$98.41K$189.99K$151.45K$147.57K$147.23K$177.23K––
IFPG [Member]–––––$780.82K$647.92K$872.29K$601.12K$843.57K$825.68K$841.42K––
Biosensor Platform Technology [Member]–––––$121.32K$93.21K$126.13K–$64.08K$91.59K$64.55K––

By region

RevenueQ4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24% of revenueYoY
United Kingdom$1.20M$1.04M$846.88K$1.07M$788.25K$707.78K$548.16K$823.84K$683.79K$799.81K$655.45K$755.15K104.5%+51.8%
Asia Pacific [Member]$5.57K$3.67K$1.54K$1.69K$17.34K$5.28K$5.97K$580––––0.5%-67.9%
Other Country [Member]–$11.89K$40.73K$36.22K$43.55K$11.16K$41.22K$36.78K$22.35K$15.20K$91.81K$32.86K––
Australia–––––$5.28K$5.97K$580$10.28K$8.79K$16.81K$8.08K––
Americas [Member]–$4.09K$7.63K$4.97K–$4.65K$12.15K$11.10K––––––

From the segment and revenue-disaggregation notes of Intelligent Bio Solutions's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.